Evidence map›Paper›PMID 30134003›Full record

ArticleJournal of cellular and molecular medicine2018

LINC00312 represses proliferation and metastasis of colorectal cancer cells by regulation of miR-21.

Gang Li, Changming Wang, Yongbing Wang, Bin Xu, Wenzhong Zhang

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. A review on the role of LINC01133 in cancers.Cancer cell international · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gang LiDepartment of General Surgery, Shanghai Pudong New Area People Hospital affiliated to Shanghai University of Medicine & Health Sciences, Shanghai, China.ORCID 0000-0003-0453-6294
Changming WangDepartment of Gastrointestinal Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Yongbing WangDepartment of General Surgery, Shanghai Pudong New Area People Hospital affiliated to Shanghai University of Medicine & Health Sciences, Shanghai, China.
Bin XuDepartment of General Surgery, Shanghai Pudong New Area People Hospital affiliated to Shanghai University of Medicine & Health Sciences, Shanghai, China.
Wenzhong ZhangDepartment of General Surgery, Shanghai Pudong New Area People Hospital affiliated to Shanghai University of Medicine & Health Sciences, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) have emerged as important regulators of cancer, including colorectal cancer (CRC). The exact expression pattern of long intergenic noncoding RNA 00312 (LINC00312) in CRC and its mechanisms of action have not been reported. Here, we found that LINC00312 is underexpressed in CRC tissues and cell lines. Functional experiments suggested that LINC00312 suppresses growth, migration and invasion of CRC cells in vitro and attenuates tumour proliferation and metastasis in vivo. Mechanistically, LINC00312 was found to regulate the malignancy of CRC cells by binding to miR-21 and by functioning as a tumour suppressor targeting PTEN. Overexpression of miR-21 or knockdown of PTEN attenuated the LINC00312-mediated inhibition of CRC cell proliferation and invasion. Taken together, our results elucidate the role of the LINC00312-miR-21-PTEN axis in CRC cell proliferation and tumour progression and may lead to new lncRNA-based diagnostics or therapeutics for CRC.

Indexed as

AnimalsCell MovementCell ProliferationColorectal NeoplasmsGene Expression Regulation, NeoplasticHeterograftsHT29 CellsHumansMiceMicroRNAsNeoplasm InvasivenessNeoplasm MetastasisPTEN PhosphohydrolaseRNA, Long NoncodingLINC00312 long non-coding RNA, humanMicroRNAsMIRN21 microRNA, humanPTEN PhosphohydrolasePTEN protein, humanRNA, Long Noncodingcolorectal cancerLINC00312metastasismiR-21PTEN

Identifiers

PMID30134003
PMCPMC6201213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.